CN105505853A - Low-serum culture medium for high-density suspension culture of BHK-21 cells and application of low-serum culture medium in proliferation of FMDVs (foot and mouth disease viruses) - Google Patents
Low-serum culture medium for high-density suspension culture of BHK-21 cells and application of low-serum culture medium in proliferation of FMDVs (foot and mouth disease viruses) Download PDFInfo
- Publication number
- CN105505853A CN105505853A CN201510980603.7A CN201510980603A CN105505853A CN 105505853 A CN105505853 A CN 105505853A CN 201510980603 A CN201510980603 A CN 201510980603A CN 105505853 A CN105505853 A CN 105505853A
- Authority
- CN
- China
- Prior art keywords
- cell
- bhk
- cells
- culture
- medium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0684—Cells of the urinary tract or kidneys
- C12N5/0686—Kidney cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/40—Nucleotides, nucleosides or bases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/50—Soluble polymers, e.g. polyethyleneglycol [PEG]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/74—Undefined extracts from fungi, e.g. yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
- C12N2770/32151—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
本发明公开了一种用于BHK-21细胞高密度悬浮培养的低血清培养基及其在口蹄疫病毒增殖培养中的应用。本发明通过研究BHK-21细胞生长过程中葡萄糖等营养物质的代谢水平和相互调节,提出了个性化BHK-21细胞低血清培养基,包含氨基酸部分、维生素部分、平衡盐部分和其它添加物部分。使用本发明培养基用于BHK-21细胞的高密度悬浮培养,能够大大提高细胞对营养物质的有效利用率,降低代谢副产物浓度,从而提高细胞培养效能;此外,采用本发明培养基培养获得的BHK-21细胞,对FMDV不同血清型敏感性增加,病毒有效抗原146S含量得到大幅度提高,可达到细胞生长的高效性、细胞生长的可控性及代谢副产物浓度最低化的目的,使生物制品的生产效率更高,生产成本更低,具有显著的经济效益。The invention discloses a low-serum medium for high-density suspension culture of BHK-21 cells and its application in the proliferation and culture of foot-and-mouth disease virus. The present invention proposes a personalized BHK-21 cell low-serum medium by studying the metabolic level and mutual regulation of nutrients such as glucose in the growth process of BHK-21 cells, including amino acid parts, vitamin parts, balanced salt parts and other additive parts . Using the medium of the present invention for high-density suspension culture of BHK-21 cells can greatly improve the effective utilization of nutrients by cells and reduce the concentration of metabolic by-products, thereby improving cell culture efficiency; in addition, using the medium of the present invention to obtain The BHK-21 cells of BHK-21 cells have increased sensitivity to different serotypes of FMDV, and the content of the effective antigen 146S of the virus has been greatly increased, which can achieve the purpose of high efficiency of cell growth, controllability of cell growth and minimum concentration of metabolic by-products, so that The production efficiency of biological products is higher, the production cost is lower, and it has significant economic benefits.
Description
技术领域technical field
本发明涉及一种BHK-21细胞全悬浮高密度低血清个性化培养基的研制及其在口蹄疫病毒增殖中的应用,属于兽用生物制药领域。The invention relates to the development of a BHK-21 cell full-suspension high-density low-serum individualized culture medium and its application in the proliferation of foot-and-mouth disease virus, belonging to the field of veterinary biopharmaceuticals.
背景技术Background technique
随着生物制品技术的快速发展,我国现行口蹄疫灭活疫苗生产工艺,从使用传统的转瓶贴壁细胞培养,发展为生物反应器大规模细胞悬浮培养。利用生物反应器进行大规模细胞培养,可以大幅度提高规模化动物细胞培养的单位产量,实现细胞的高密度培养、高密度表达,同时可以简化生产工艺,降低生产成本,保证大规模生产的产品质量。而普通培养基无法满足反应器中细胞的高密度培养,也不能够支持反应器独特的培养方式。在国外个性化培养基已成为培养基发展的主流,已被普遍使用并产生极大的经济效益。适宜的培养基配方可提高细胞的培养密度和细胞活率,提高病毒产量。因此如何根据规模化细胞培养工艺的不同,研发个性化培养基,提高目标产品的稳定性、产出率,是目前本领域的研究热点和难点。With the rapid development of biological product technology, the current production process of foot-and-mouth disease inactivated vaccine in my country has developed from the use of traditional spinner bottle adherent cell culture to large-scale cell suspension culture in bioreactors. The use of bioreactors for large-scale cell culture can greatly increase the unit output of large-scale animal cell culture, realize high-density culture and high-density expression of cells, simplify the production process, reduce production costs, and ensure large-scale production of products quality. However, ordinary medium cannot meet the high-density culture of cells in the reactor, nor can it support the unique culture mode of the reactor. Personalized medium has become the mainstream of medium development in foreign countries, has been widely used and has produced great economic benefits. Appropriate medium formula can increase cell culture density and cell viability, and increase virus yield. Therefore, how to develop personalized culture medium according to different large-scale cell culture processes and improve the stability and yield of target products is a research hotspot and difficulty in this field.
本发明根据现有的细胞株、细胞培养方式,目的产物及生产工艺,细胞代谢及营养物质的需求,确立培养基设计方案,建立各种营养物质的检测方法,分析细胞代谢流,设计培养基配方,与商业化培养基比较,血清含量降低30%,细胞对营养物质的有效利用率提高,代谢副产物浓度降低,提高了BHK-21细胞的培养密度和细胞活率,细胞产能增加28%,经口蹄疫病毒增殖,细胞对FMDV不同血清型敏感性增加,抗原含量稳定且提高幅度达43%,从而保证在稳定的细胞培养过程下,兼顾培养细胞的高密度水平和生产病毒抗原的高浓度,生产高质量的病毒疫苗,为目标产品品质的提高和产业化生产奠定了基础。According to the existing cell lines, cell culture methods, target products and production processes, cell metabolism and nutrient requirements, the present invention establishes a culture medium design scheme, establishes detection methods for various nutrients, analyzes cell metabolic flow, and designs a culture medium Formula, compared with the commercial culture medium, the serum content is reduced by 30%, the effective utilization of nutrients by cells is improved, the concentration of metabolic by-products is reduced, the culture density and cell viability of BHK-21 cells are improved, and the cell production capacity is increased by 28%. After FMD virus proliferation, the sensitivity of cells to different serotypes of FMDV increases, and the antigen content is stable and increased by 43%, so as to ensure the high density of cultured cells and the production of high concentrations of virus antigens in a stable cell culture process. , to produce high-quality virus vaccines, laying the foundation for the improvement of target product quality and industrialized production.
发明内容Contents of the invention
本发明的目的之一是提供一种低成本、成分较为明确的适用于BHK-21细胞高密度悬浮培养的低血清个性化培养基。One of the objectives of the present invention is to provide a low-serum personalized culture medium suitable for high-density suspension culture of BHK-21 cells with low cost and relatively clear components.
本发明的目的之二是提供所述培养基在BHK-21细胞高密度悬浮培养中的用途。The second object of the present invention is to provide the use of the culture medium in high-density suspension culture of BHK-21 cells.
本发明的目的之三是提供所述培养基在病毒增殖中的用途。The third object of the present invention is to provide the use of the culture medium in virus propagation.
为了达到上述目的,本发明采用了以下技术手段:In order to achieve the above object, the present invention adopts the following technical means:
1、研制培养基策略方法由以下步骤完成:1. The strategy method of developing culture medium is completed by the following steps:
(1)、细胞基础培养液的配制与准备(1) Preparation and preparation of cell basal culture medium
称取MEM培养基粉末溶于一定量蒸馏水(蒸馏水温度低于40℃)中,充分搅拌溶解,用氢氧化钠或盐酸调节pH值至6.95~7.15,最后定容即得BHK-21细胞悬浮培养用培养基。Weigh the MEM medium powder and dissolve it in a certain amount of distilled water (the temperature of distilled water is lower than 40°C), stir well to dissolve, adjust the pH value to 6.95-7.15 with sodium hydroxide or hydrochloric acid, and finally make the volume to obtain BHK-21 cell suspension culture Use medium.
(2)、细胞复苏与培养(2), cell recovery and culture
从悬浮BHK-21细胞工作库取细胞一支,复苏后静置培养于T100细胞方瓶内,传2~3代,细胞长满单层后用胰蛋白酶消化,补加适量细胞培养液转移至1000ml三角瓶中,37℃振荡悬浮培养,摇床转速为90r/min,pH值为7.0~7.2,每日用NaHCO3调pH值。待细胞培养体积达到规定数量后,收集细胞,转入5L生物反应器中培养,培养设定参数:温度为37.0~37.5℃,pH值为7.0~7.2,DO值为60.0%~80.0%,搅拌转速为80~120r/min,培养50h传代培养。One cell was taken from the suspension BHK-21 cell working bank, and after resuscitation, it was cultured in a T100 cell square bottle, and passed on for 2 to 3 generations. After the cells covered a single layer, they were digested with trypsin, and an appropriate amount of cell culture medium was added and transferred to In a 1000ml Erlenmeyer flask, shake suspension culture at 37°C, the shaker speed is 90r/min, the pH value is 7.0-7.2, and the pH value is adjusted with NaHCO 3 every day. After the cell culture volume reaches the specified number, collect the cells and transfer them to a 5L bioreactor for culture. The culture setting parameters are: temperature 37.0-37.5°C, pH value 7.0-7.2, DO value 60.0%-80.0%, stirring The rotation speed is 80-120r/min, and the culture is subcultured for 50 hours.
(3)、BHK-21细胞在基础培养基中细胞生长代谢参数的控制(3), BHK-21 cells in the control of cell growth metabolism parameters in basal medium
①按上述步骤2中所得到的细胞在5L生物反应器进行批式培养,以细胞密度和细胞活率为评价指标,在培养0h、24h、48h、72h和96h取细胞样,在4℃、1000rpm条件下离心5min,留取细胞上清液;① Batch culture the cells obtained in the above step 2 in a 5L bioreactor, and take cell samples at 0h, 24h, 48h, 72h and 96h of culture based on the evaluation index of cell density and cell viability, and store them at 4°C, Centrifuge at 1000rpm for 5min, and collect the cell supernatant;
②将上述①所得细胞上清液进行主要营养物质葡萄糖和谷氨酰胺检测分析,葡萄糖和谷氨酰胺浓度和采用NOVAPLUS100生化分析仪测定;② The cell supernatant obtained in the above ① is subjected to the detection and analysis of the main nutrients glucose and glutamine, and the concentration of glucose and glutamine is measured by NOVAPLUS100 biochemical analyzer;
③将上述①所得细胞上清液进行主要营养物质氨基酸的检测分析,氨基酸浓度采用柱前衍生法,超高液相色谱仪分析,衍生试剂采用乙腈稀释至一定浓度的PITC和TEA溶液,备用;③ The cell supernatant obtained in the above ① is subjected to the detection and analysis of the main nutrient amino acid, the amino acid concentration is analyzed by the pre-column derivatization method, and the ultra-high liquid chromatograph is used for analysis, and the derivatization reagent is diluted to a certain concentration of PITC and TEA solution with acetonitrile, and set aside;
④将上述①所得细胞上清液进行主要代谢副产物氨和乳酸的检测分析,采用NOVAPLUS100生化分析仪检测。④ The cell supernatant obtained in the above ① was subjected to the detection and analysis of the main metabolic by-products ammonia and lactic acid, and the NOVAPLUS100 biochemical analyzer was used for detection.
(4)、培养基配方的确定(4) Determination of medium formula
结合上述步骤(3)的细胞代谢流监测结果,确定主要影响细胞生长代谢的各个营养物质的含量,特别是葡萄糖浓度不低于16.0mmol/L、谷氨酰胺浓度不低于4.5mmol/L,两者浓度比例约3.5:1;在细胞培养结束时氨基酸不低于初始含量5%;确定了细胞代谢过程中对副产物的耐受浓度,即乳酸浓度不高于19mmol/L、氨浓度不高于8mmol/L,从而确定了BHK-21细胞个性化低血清培养基配方,并将其命名为ZN-MEM。Combining the monitoring results of cell metabolic flow in the above step (3), determine the content of various nutrients that mainly affect cell growth and metabolism, especially the concentration of glucose is not lower than 16.0mmol/L, and the concentration of glutamine is not lower than 4.5mmol/L, The concentration ratio of the two is about 3.5:1; at the end of cell culture, the amino acid is not lower than 5% of the initial content; the tolerance concentration of by-products in the process of cell metabolism is determined, that is, the concentration of lactic acid is not higher than 19mmol/L, and the concentration of ammonia is not higher than Higher than 8mmol/L, thus determined the BHK-21 cell personalized low serum medium formula, and named it ZN-MEM.
(5)培养基配方的实际效果验证(5) Verification of the actual effect of the medium formula
5.15L和500L生物反应器连续传代培养5.15L and 500L bioreactor continuous subculture
将上述步骤4得到的ZN-MEM培养液,在5L和500L生物反应器进行BHK-21细胞的悬浮培养,设定参数:温度为37.0~37.5℃,pH值为7.0~7.2,DO值为60.0%~80.0%,搅拌转速为60~80r/min,培养0h、24h、48h、72h和96h细胞样品,800r/min进行离心,留上清液,采用细胞分析仪分析,考察BHK-21细胞在不同规模培养条件下,细胞密度和细胞活率变化情况。Use the ZN-MEM culture solution obtained in the above step 4 to carry out suspension culture of BHK-21 cells in 5L and 500L bioreactors, set parameters: temperature is 37.0-37.5°C, pH value is 7.0-7.2, DO value is 60.0 %~80.0%, the stirring speed is 60~80r/min, culture the cell samples for 0h, 24h, 48h, 72h and 96h, centrifuge at 800r/min, keep the supernatant, use the cell analyzer to analyze, investigate the BHK-21 cells in Changes in cell density and cell viability under different scale culture conditions.
结果:培养48小时传代,细胞密度均在3.8×106个/ml以上,且其活率均高于94%。Results: The cells were subcultured for 48 hours, and the cell density was above 3.8×10 6 cells/ml, and the viability was higher than 94%.
5.2低血清培养细胞的病毒增殖效果5.2 Effect of virus proliferation on cells cultured in low serum
取上述步骤5.1中500L生物反应器收获的细胞,分别接种口蹄疫病毒A型、O型和Asia1型,设定控制参数:温度为36.5~37.0℃,pH值为7.4~7.6,DO值为Take the cells harvested from the 500L bioreactor in the above step 5.1, and inoculate the FMD virus type A, O and Asia1 respectively.
60.0%~70.0%,搅拌转速为40~60r/min。当细胞病变率达90%以上,收获病毒,记录收获病毒的时间,按常规法测定收获病毒液的TCID50、LD50和有效抗原146S含量。60.0%~70.0%, the stirring speed is 40~60r/min. When the cytopathic rate reached over 90%, the virus was harvested, the time of harvesting the virus was recorded, and the TCID 50 , LD 50 , and effective antigen 146S content of the harvested virus liquid were measured by conventional methods.
结果:经检测,收获病毒液的TCID50、LD50均符合疫苗工业化生产要求,相较于常规方法,细胞病变时间缩短约14%,有效抗原146S含量提高43%。Results: After testing, the TCID 50 and LD 50 of the harvested virus liquid all met the requirements of industrialized vaccine production. Compared with the conventional method, the cytopathic time was shortened by about 14%, and the effective antigen 146S content was increased by 43%.
在上述研究的基础上,本发明提出了一种用于BHK-21细胞高密度悬浮培养的低血清培养基,命名为ZN-MEM,包括氨基酸部分,平衡盐部分,维生素部分、其它添加物、血清以及蒸馏水,pH值7.0~7.2,其中,血清添加浓度为1%(v/v),其它各原料物质在培养基中的终浓度为:On the basis of the above research, the present invention proposes a low-serum medium for high-density suspension culture of BHK-21 cells, named ZN-MEM, including amino acid part, balanced salt part, vitamin part, other additives, Serum and distilled water, pH value 7.0~7.2, wherein, the added concentration of serum is 1% (v/v), the final concentration of other raw materials in the culture medium is:
①氨基酸部分,包括:①Amino acid part, including:
②平衡盐部分,包括:②Balanced salt part, including:
③维生素部分,包括:③Vitamin part, including:
④其它添加物,包括:④Other additives, including:
在本发明中,优选的,其它各原料物质在培养基中的终浓度为:①氨基酸部分,包括:In the present invention, preferably, the final concentration of other raw materials in the culture medium is: ① amino acid part, including:
②平衡盐部分,包括:②Balanced salt part, including:
③维生素部分,包括:③Vitamin part, including:
④其它添加物,包括:④Other additives, including:
进一步的,本发明还提出了所述的培养基在进行BHK-21细胞的悬浮培养中的用途。Furthermore, the present invention also proposes the use of the medium in the suspension culture of BHK-21 cells.
在本发明中,优选的,所述的悬浮培养,其培养条件为:接种密度为0.50×106个/ml,培养温度为37.0~37.5℃,pH值为7.0~7.2,DO值为60.0%~80.0%,搅拌转速为60~80r/min,培养48h进行传代。In the present invention, preferably, the culture conditions of the suspension culture are as follows: the inoculation density is 0.50× 106 /ml, the culture temperature is 37.0-37.5°C, the pH value is 7.0-7.2, and the DO value is 60.0%. ~80.0%, the stirring speed is 60~80r/min, cultured for 48h for passage.
更进一步的,本发明还提出了所述的培养基在以BHK-21细胞作为宿主细胞进行病毒增殖中的用途。Furthermore, the present invention also proposes the use of the culture medium in virus propagation using BHK-21 cells as host cells.
在本发明中,优选的,所述的病毒增殖包括向经本发明所述的培养基培养得到的BHK-21细胞接种病毒,设定控制参数为:温度为36.5~37.0℃,pH值为7.4~7.6,DO值为60.0%~70.0%,搅拌转速为40~60r/min,进行病毒增殖培养。In the present invention, preferably, the virus propagation includes inoculating the virus into the BHK-21 cells cultured in the medium of the present invention, and the control parameters are set as follows: the temperature is 36.5-37.0°C, and the pH value is 7.4 ~7.6, the DO value is 60.0%~70.0%, the stirring speed is 40~60r/min, and the virus multiplication culture is carried out.
其中,所述的病毒为优选口蹄疫病毒,更优选为FMD/O/MYA98/BY/2010、FMD/Re-AWH/09型或FMD/Asia1JSL/06。Wherein, the virus is preferably foot-and-mouth disease virus, more preferably FMD/O/MYA98/BY/2010, FMD/Re-AWH/09 or FMD/Asia1JSL/06.
本发明通过研究BHK-21细胞对葡萄糖、谷氨酰胺、氨基酸等营养物质的代谢水平和多因素相互调节,改变或调节培养基中各种成分的种类、数量和比例,优化细胞培养环境,研制出适合于BHK-21悬浮细胞专用的个性化低血清培养基,保证在稳定的细胞培养过程下生产高质量的病毒疫苗。与当前商业化培养基相比,其优点如下:The present invention changes or adjusts the types, quantities and proportions of various components in the culture medium by studying the metabolism level of BHK-21 cells to nutrients such as glucose, glutamine and amino acids and the mutual regulation of multiple factors, and optimizes the cell culture environment. A personalized low-serum medium suitable for BHK-21 suspension cells is produced to ensure the production of high-quality virus vaccines under a stable cell culture process. Compared with current commercial media, its advantages are as follows:
1.细胞质量提升1. Cell quality improvement
1)细胞产能提高1) Increased cell production capacity
应用本发明的个性化培养基ZN-MEM,大大提高了细胞对营养物质的有效利用率,降低了代谢副产物浓度,优化了细胞生长环境,细胞生长速率增加,培养细胞的终密度大大提高,由原来的2.5×106cells/ml,增至3.8~5.0×106cells/ml,比市售培养基培养细胞密度增加近1.5~2倍,细胞生长状态稳定,细胞产能增加28%以上;The application of the personalized medium ZN-MEM of the present invention greatly improves the effective utilization of nutrients by cells, reduces the concentration of metabolic by-products, optimizes the cell growth environment, increases the cell growth rate, and greatly increases the final density of cultured cells. From the original 2.5×10 6 cells/ml to 3.8-5.0×10 6 cells/ml, the cell density increased by nearly 1.5-2 times compared with the commercial medium, the cell growth state was stable, and the cell production capacity increased by more than 28%;
2)细胞活性提高2) Increased cell activity
避免了营养物质的过剩或缺乏,降低了培养液中有毒代谢副产物的浓度,使细胞营养环境最优化,有效资源得到循环利用,同时降低了规模化细胞培养过程中细胞凋亡率,细胞活性提高;It avoids the excess or lack of nutrients, reduces the concentration of toxic metabolic by-products in the culture medium, optimizes the nutritional environment of cells, recycles effective resources, and reduces the apoptosis rate and cell viability in the process of large-scale cell culture. improve;
3)细胞扩增比率提高3) Increased cell expansion ratio
细胞生长速度快,市售的BH21细胞培养基细胞传代放大比例1:4左右,而应用优化的培养基细胞扩增比例1:6~1:10,提高了40%,单位时间内细胞产量提高。同时,细胞扩增比例的提高,减少了动力设备与加压设备,大大降低成本,产生间接经济效益。The cell growth rate is fast. The cell subculture ratio of the commercially available BH21 cell culture medium is about 1:4, while the cell proliferation ratio of the optimized medium is 1:6-1:10, which is 40% higher, and the cell yield per unit time is increased. . At the same time, the increase of the cell expansion ratio reduces the power equipment and pressurization equipment, greatly reduces the cost, and produces indirect economic benefits.
2、疫苗抗原质量提升2. Improving the quality of vaccine antigens
以BHK-21细胞为基质,应用本发明的个性化培养基,优化了细胞培养环境,提高了培养细胞密度和细胞活率,细胞产能增加,细胞对FMD不同型病毒感染的敏感性及表达水平提高,使得口蹄疫完整病毒粒子146S的含量得到大幅度的提高,146S含量达商业化培养的2倍以上,为口蹄疫产品品质的提高奠定了基础。Using BHK-21 cells as a matrix, applying the personalized culture medium of the present invention, optimizes the cell culture environment, improves the cultured cell density and cell viability, increases the cell production capacity, and the sensitivity and expression level of cells to different types of FMD virus infection The improvement makes the content of 146S of the complete virion of FMD greatly increased, and the 146S content reaches more than 2 times that of commercial culture, which lays the foundation for the improvement of the quality of FMD products.
3、培养基经济成本降低3. The economic cost of culture medium is reduced
目前,动物口蹄疫预防接种中使用的口蹄疫油佐剂灭活疫苗,细胞生产占其生产直接成本的80%以上。应用常规培养基细胞生产过程中,平均每升营养液直接成本为5.8元,使用本发明的个性化培养基培养细胞,每升营养液成本降低至4.9元,每升营养液细胞成本下降约18%。以年生产口蹄疫疫苗15亿毫升计算,需要细胞营养液约7.5亿毫升,年产生直接经济约60万元以上。At present, cell production accounts for more than 80% of the direct cost of the FMD oil adjuvant inactivated vaccine used in animal FMD vaccination. In the production process of cells using conventional culture medium, the average direct cost per liter of nutrient solution is 5.8 yuan. Using the personalized medium of the present invention to cultivate cells, the cost per liter of nutrient solution is reduced to 4.9 yuan, and the cost of cells per liter of nutrient solution is reduced by about 18 yuan. %. Based on the annual production of 1.5 billion milliliters of foot-and-mouth disease vaccine, about 750 million milliliters of cell nutrient solution is needed, and the annual direct economic output is more than 600,000 yuan.
另外,血清浓度比商业化培养基降低了30%,间接地又降低了生产成本,减轻了后续浓缩纯化工艺的压力,降低了疫苗生产过程中可能存在的潜在生物安全风险。In addition, the serum concentration is 30% lower than that of the commercial medium, which indirectly reduces the production cost, reduces the pressure on the subsequent concentration and purification process, and reduces the potential biosafety risks that may exist in the vaccine production process.
4、培养基配制过程精简化4. The process of medium preparation is simplified
本发明的个性化培养基配制过程简单,试剂可溶性增强,不需要投入大量的时间和劳动力,一定程度节约了人员的投入。The preparation process of the personalized culture medium of the present invention is simple, the solubility of reagents is enhanced, and a large amount of time and labor are not required to be invested, which saves personnel input to a certain extent.
综上,使用本发明的个性化培养基培养细胞,细胞培养特性提高,细胞产量增加,疫苗的有效抗原含量和免疫效果得到提高;利用本发明的个性化培养基培养的细胞生产口蹄疫病毒,疫苗生产直接成本大大降低,目前,该培养基在我公司中试生产线上成功应用,并产生了显著的经济效益,具有广泛的应用前景。In summary, using the personalized culture medium of the present invention to cultivate cells, the cell culture characteristics are improved, the cell yield is increased, and the effective antigen content and immune effect of the vaccine are improved; the cells produced by the personalized culture medium of the present invention are used to produce foot-and-mouth disease virus, vaccine The direct cost of production is greatly reduced. At present, this medium has been successfully applied in the pilot production line of our company, and has produced significant economic benefits, and has a wide application prospect.
附图说明Description of drawings
图1为BHK-21细胞增殖过程中所需氨基酸种类和含量分布图;Fig. 1 is the required amino acid species and content distribution diagram in the process of BHK-21 cell proliferation;
图2为细胞增殖所需氨基酸量;Figure 2 is the amount of amino acids required for cell proliferation;
图3为细胞增殖所需葡萄糖量;Fig. 3 is the amount of glucose required for cell proliferation;
图4为细胞代谢副产物浓度变化;Fig. 4 is the change of concentration of by-products of cell metabolism;
图5为不同规模下培养细胞稳定性传代图;Figure 5 is a graph showing the stability and passage of cultured cells under different scales;
图6为BHK-21细胞在四种培养基中细胞形态;Figure 6 is the cell morphology of BHK-21 cells in four culture media;
图7为BHK-21细胞在四种培养基中批式培养的生长曲线;Fig. 7 is the growth curve of BHK-21 cell batch culture in four kinds of culture medium;
图8为BHK-21批式培养过程中葡萄糖和乳酸浓度的变化;Fig. 8 is the variation of glucose and lactic acid concentration in BHK-21 batch culture process;
图9为BHK-21批式培养过程中谷氨酰胺和氨浓度的变化。Fig. 9 shows the changes of glutamine and ammonia concentrations during batch culture of BHK-21.
具体实施方式detailed description
下面结合具体实施例和附图来进一步描述本发明,本发明的优点和特点将会随着描述而更为清楚。但这些实施例仅是范例性的,并不对本发明的范围构成任何限制。本领域技术人员应该理解的是,在不偏离本发明的精神和范围下可以对本发明技术方案的细节和形式进行修改或替换,但这些修改和替换均落入本发明的保护范围内。The present invention will be further described below in combination with specific embodiments and accompanying drawings, and the advantages and characteristics of the present invention will become clearer along with the description. However, these embodiments are only exemplary and do not constitute any limitation to the scope of the present invention. Those skilled in the art should understand that the details and forms of the technical solutions of the present invention can be modified or replaced without departing from the spirit and scope of the present invention, but these modifications and replacements all fall within the protection scope of the present invention.
实施例一BHK-21细胞营养代谢研究及培养基配方的确定Example 1 BHK-21 Cell Nutritional Metabolism Research and Determination of Medium Formula
1材料1 material
1.1BHK-21细胞取自中农威特生物科技股份有限公司建立的BHK-21悬浮细胞工作细胞库,批号为BHK-21/W/S-201202,经放大培养检验合格后使用。1.1 BHK-21 cells were taken from the BHK-21 suspension cell working cell bank established by Zhongnong Weite Biotechnology Co., Ltd., the batch number is BHK-21/W/S-201202, and they were used after the scale-up culture inspection passed.
1.2血清新生牛血清,购自合格供应商,按照中农威特生物科技股份有限公司新生牛血清内控质量标准检验合格后使用。1.2 Serum Newborn bovine serum was purchased from a qualified supplier and used after passing the internal control quality standard for newborn bovine serum of Zhongnong Weite Biotechnology Co., Ltd.
1.3试剂与设备1.3 Reagents and equipment
主要试剂:美国waters氨基酸分析色谱柱(5μm,150×4.6mmol);20种氨基酸标样;乙腈(色谱纯);醋酸钠(分析纯);醋酸(分析纯);三乙胺(TEA);苯异硫氰酸酯(PITC)等。Main reagents: American waters amino acid analysis column (5μm, 150×4.6mmol); 20 amino acid standard samples; acetonitrile (chromatographically pure); sodium acetate (analytical pure); acetic acid (analytical pure); triethylamine (TEA); Phenylisothiocyanate (PITC), etc.
主要仪器:细胞分析仪(德国INNOVATIS公司);美国Waters高效液相色谱仪;NOVAPLUS100生化分析仪;5L生物反应器(美国NBS);显微镜(日本Olympus);5L生物反应器(美国NBS),Main instruments: cell analyzer (Innovatis, Germany); American Waters high-performance liquid chromatography; NOVAPLUS100 biochemical analyzer; 5L bioreactor (US NBS); microscope (Japan Olympus); 5L bioreactor (US NBS),
1.4细胞基础培养液:称取一定量MEM培养基粉末溶于一定量蒸馏水(蒸馏水温度低于40℃)中,充分搅拌溶解,用氢氧化钠或盐酸调节pH值至6.95~7.15,最后定容即得BHK-21细胞悬浮培养用基础培养液。1.4 Cell basal culture medium: Weigh a certain amount of MEM medium powder and dissolve it in a certain amount of distilled water (distilled water temperature is lower than 40°C), stir well to dissolve, adjust the pH value to 6.95-7.15 with sodium hydroxide or hydrochloric acid, and finally make up to volume The basal culture medium for suspension culture of BHK-21 cells was obtained.
2方法2 methods
2.1主要测定方法2.1 Main measurement methods
2.1.1细胞计数与分析2.1.1 Cell counting and analysis
2.1.1.1取样:用无菌的吸管吸取细胞;2.1.1.1 Sampling: absorb the cells with a sterile pipette;
2.1.1.2加样:用吸管轻轻吹打细胞悬液,用移液器吸取细胞样品20ul与CASYTON细胞分析缓冲液10ml反复混匀,用细胞分析仪进行分析。2.1.1.2 Adding samples: Gently pipette the cell suspension, use a pipette to absorb 20ul of the cell sample and mix it repeatedly with 10ml of CASYTON cell analysis buffer, and analyze it with a cell analyzer.
2.1.1.3检测:根据细胞分析仪测定的结果,计算细胞活率、密度及细胞生长比率,确定细胞的增殖能力。2.1.1.3 Detection: Calculate the cell viability, density and cell growth ratio according to the results measured by the cell analyzer to determine the proliferation ability of the cells.
2.1.2氨基酸检测分析:采用HPLC进行检测2.1.2 Amino acid detection and analysis: detection by HPLC
2.2细胞培养及方法2.2 Cell culture and methods
2.2.1细胞复苏与培养2.2.1 Cell Recovery and Culture
①从悬浮BHK-21细胞工作库取细胞一支,迅速置于40℃水浴中解冻;①Take one cell from the suspended BHK-21 cell working bank, and quickly place it in a 40°C water bath to thaw;
②将①所得到的细胞在1000rpm转速下,离心4min,弃上清,加入适量含有5%血清的培养液重悬,复苏后静置培养于T100细胞方瓶内,传2~3代,细胞长满单层后用胰蛋白酶消化;②Centrifuge the cells obtained in ① at 1000rpm for 4min, discard the supernatant, add an appropriate amount of culture medium containing 5% serum to resuspend, and culture it in a T100 cell square bottle after recovery, pass 2 to 3 generations, and the cells Digest with trypsin after overgrown monolayer;
③将②所得到的细胞转移至250ml三角瓶中,37℃振荡悬浮培养,摇床转速为90r/min,pH值7.0~7.2,每日用NaHCO3调pH值,培养50h传代培养;③Transfer the cells obtained in ② into a 250ml Erlenmeyer flask, shake and suspend culture at 37°C, the shaker speed is 90r/min, the pH value is 7.0-7.2, adjust the pH value with NaHCO 3 every day, and culture for 50h for subculture;
④待细胞培养体积达到100ml,细胞密度3.0×106cells/ml,细胞活率93%以上,逐级放大,收集细胞,转入5L生物反应器培养,设定参数:温度为37.0~37.5℃,pH值为7.0~7.2,DO值为60.0%~80.0%,搅拌转速为80~120r/min,培养50h传代培养。④ When the cell culture volume reaches 100ml, the cell density is 3.0×10 6 cells/ml, and the cell viability is above 93%, scale up step by step, collect the cells, transfer them to a 5L bioreactor for cultivation, and set the parameters: the temperature is 37.0~37.5°C , the pH value is 7.0-7.2, the DO value is 60.0%-80.0%, the stirring speed is 80-120r/min, and the culture is subcultured for 50h.
2.2.2BHK-21细胞氨基酸、葡萄糖及代谢副产物需求研究2.2.2 Requirements of amino acids, glucose and metabolic by-products in BHK-21 cells
1)按上述步骤2中④所得到的细胞在5L生物反应器进行批式培养,以细胞密度和细胞活率为评价指标,在培养0h、24h、48h、72h和96h取细胞样,在4℃、1000rpm条件下离心5min,留取细胞上清液;1) Carry out batch culture in 5L bioreactor according to the cells obtained in ④ in the above step 2, and take cell samples at 0h, 24h, 48h, 72h and 96h of culture with the evaluation index of cell density and cell viability, and in 4 Centrifuge at 1000rpm for 5min at ℃, and collect the cell supernatant;
2)将上述1)所得细胞上清液进行主要营养物质葡萄糖和谷氨酰胺检测分析,葡萄糖和谷氨酰胺浓度采用NOVAPLUS100生化分析仪测定;2) The cell supernatant obtained in the above 1) is subjected to the detection and analysis of the main nutrients glucose and glutamine, and the concentration of glucose and glutamine is measured by NOVAPLUS100 biochemical analyzer;
3)将上述1)所得细胞上清液进行主要营养物质氨基酸的检测分析,氨基酸浓度采用超高液相柱前衍生法,具体步骤为:3) The cell supernatant obtained in the above 1) is subjected to the detection and analysis of the main nutrient amino acid, and the concentration of the amino acid adopts the ultra-high liquid phase pre-column derivatization method, and the specific steps are:
①样品预处理:对需要检测的细胞培养基,以1000r/min、4℃条件离心10min,取上清备用;①Sample pretreatment: centrifuge the cell culture medium to be tested at 1000r/min, 4°C for 10min, and take the supernatant for later use;
②衍生试剂的配制:分别取12uL的PITC和144uL的TEA用乙腈稀释至1000uL,备用;②Preparation of derivatization reagents: take 12uL of PITC and 144uL of TEA and dilute to 1000uL with acetonitrile, and set aside;
③样品衍生反应:取上清液200uL,同时分别取PITC、TEA各100uL,涡旋振荡30s,室温萃取1h,立即用等体积正己烷终止10min,取上清用0.22μm滤膜过滤,备用,样品的衍生方法与标准品同;③ Sample derivatization reaction: Take 200uL of the supernatant, and at the same time take 100uL of PITC and TEA respectively, vortex for 30s, extract at room temperature for 1h, immediately stop with an equal volume of n-hexane for 10min, take the supernatant and filter it with a 0.22μm filter membrane, and set aside. The derivation method of the sample is the same as that of the standard;
④流动相:A和B两种溶液梯度洗脱。A液为醋酸钠溶液;B液为乙腈溶液,C液为洗液,即20%的乙腈溶液;流动相在使用之前经0.22μm滤膜过滤,并用超声波脱气10min;④Mobile phase: two solutions of A and B for gradient elution. Solution A is sodium acetate solution; solution B is acetonitrile solution, and solution C is washing solution, that is, 20% acetonitrile solution; the mobile phase is filtered through a 0.22 μm filter membrane and degassed by ultrasonic waves for 10 minutes before use;
⑤标准曲线制定:将含20种氨基酸的标准溶液进行稀释,浓度分别为0.1mmol/L、0.25mmol/L、0.5mmol/L、1.0mmol/L;5. standard curve is formulated: the standard solution containing 20 kinds of amino acids is diluted, and concentration is respectively 0.1mmol/L, 0.25mmol/L, 0.5mmol/L, 1.0mmol/L;
⑥平衡色谱柱:先用C液对氨基酸分析柱进行清洗,再用A液平衡色谱柱,待基线平衡为止;6. Equilibrate the chromatographic column: first use liquid C to clean the amino acid analysis column, then use liquid A to balance the chromatographic column until the baseline is balanced;
⑦运行样品:上样体积为20uL,流速为1ml/min,运行时间65min,柱温30℃,检测波长254nm;⑦ Run the sample: the loading volume is 20uL, the flow rate is 1ml/min, the running time is 65min, the column temperature is 30°C, and the detection wavelength is 254nm;
⑧冲洗仪器及色谱柱,冲洗顺序为C液60ml以上,B液30ml以上;⑧Rinse the instrument and chromatographic column, the washing sequence is more than 60ml of liquid C, and more than 30ml of liquid B;
⑨数据处理,计算氨基酸含量。⑨Data processing, calculation of amino acid content.
2.2.3培养基配方的优化与应用2.2.3 Optimization and application of medium formula
依据上述步骤2.2.2检测到的细胞生长代谢参数,结合细胞代谢流监测结果,确定主要影响细胞生长代谢的各个营养物质的含量,使其细胞培养结束时,营养物质的含量不低于5%,细胞代谢过程中副产物氨浓度小于8mM、乳酸浓度小于19mM的耐受浓度极限值,进行主要营养物质的补充或降低,从而对基础目录培养基MEM进行了调整。According to the cell growth and metabolism parameters detected in the above step 2.2.2, combined with the monitoring results of the cell metabolic flow, determine the content of each nutrient that mainly affects the cell growth and metabolism, so that the content of the nutrient is not less than 5% at the end of the cell culture , the by-product ammonia concentration in the process of cell metabolism is less than 8mM, and the lactic acid concentration is less than 19mM tolerable concentration limit, and the main nutrients are supplemented or reduced, thereby adjusting the basic catalog medium MEM.
3结果3 results
3.1氨基酸、葡萄糖及代谢副产物对细胞增殖的影响通过HPLC法测定细胞接种后0h和48h培养基中20种氨基酸含量,并联合细胞生长代谢水平,确定每增长一个细胞所需各种氨基酸的量,如图1所示,进而对细胞生长过程中氨基酸的代谢进行监控。3.1 Effects of amino acids, glucose and metabolic by-products on cell proliferation Measure the contents of 20 amino acids in the culture medium at 0h and 48h after cell inoculation by HPLC, and combine the cell growth and metabolism levels to determine the amount of various amino acids required for each cell growth , as shown in Figure 1, and then monitor the metabolism of amino acids in the process of cell growth.
细胞增殖所需的氨基酸量、葡萄糖量以及细胞代谢副产物浓度变化分别如图2-图4所示。Changes in the amount of amino acids, glucose, and by-products of cell metabolism required for cell proliferation are shown in Figure 2-Figure 4, respectively.
3.2BHK-21细胞批式培养过程中主要代谢物质浓度的变化3.2 Changes in the concentrations of major metabolites during batch culture of BHK-21 cells
表1批式培养过程中主要代谢物质浓度的变化Table 1 Changes in concentration of main metabolites during batch culture
3.3培养基配方确定及验证3.3 Confirmation and verification of medium formula
结合上述细胞代谢流监测结果,确定主要影响细胞生长代谢的各个营养物质的含量及细胞代谢过程中对副产物的耐受浓度,来设计培养基配方,命名为ZN-MEM,所述培养基包括氨基酸部分,平衡盐部分,维生素部分、其它添加物、血清以及蒸馏水,pH值7.0~7.2,其中,血清添加浓度为1%(v/v),其它各原料物质在培养基中的终浓度如下表2所示:Combined with the monitoring results of the above-mentioned cell metabolic flow, determine the content of various nutrients that mainly affect cell growth and metabolism and the tolerance concentration of by-products in the process of cell metabolism to design a medium formula, named ZN-MEM, the medium includes Amino acid part, balanced salt part, vitamin part, other additives, serum and distilled water, pH value 7.0-7.2, wherein, the concentration of serum added is 1% (v/v), and the final concentration of other raw materials in the medium is as follows Table 2 shows:
表2Table 2
实施例二个性化培养基在不同培养规模下的应用Application of embodiment two personalized culture medium under different culture scales
1材料1 material
1.1BHK-21细胞取自中农威特生物科技股份有限公司建立的BHK-21悬浮细胞工作细胞库,批号为BHK-21/W/S-201201,经放大培养检验合格后使用。1.1 BHK-21 cells were taken from the working cell bank of BHK-21 suspension cells established by Zhongnong Weite Biotechnology Co., Ltd., the batch number is BHK-21/W/S-201201, and they were used after they passed the scale-up culture test.
1.2血清新生牛血清,购自合格供应商,按照中农威特生物科技股份有限公司新生牛血清内控质量标准检验合格后使用。1.2 Serum Newborn bovine serum was purchased from a qualified supplier and used after passing the internal control quality standard for newborn bovine serum of Zhongnong Weite Biotechnology Co., Ltd.
1.3培养基1.3 Medium
本发明的BHK-21低血清培养基ZN-MEM,所述培养基包括氨基酸部分,平衡盐部分,维生素部分、其他添加物、血清以及蒸馏水,pH值7.0~7.2,其中,血清添加浓度为1%(v/v),其他各原料物质在培养基中的终浓度如下表3所示:In the BHK-21 low serum medium ZN-MEM of the present invention, the medium includes amino acid part, balanced salt part, vitamin part, other additives, serum and distilled water, with a pH value of 7.0 to 7.2, wherein the added concentration of serum is 1 %(v/v), the final concentration of other raw materials in the medium is shown in Table 3 below:
将研制的ZN-MEM培养基配方委托培养基厂家进行加工,以配制50L培养液为例,其配制方法为:The developed ZN-MEM medium formula is entrusted to the medium manufacturer for processing. Taking the preparation of 50L culture medium as an example, the preparation method is as follows:
①量取90%-95%总体积的注射用水,待温度降至35~40℃,称量当量50L干粉培养基,即0.925kg干粉(不含有谷氨酰胺,PluronicF-68以及血清)溶于其中,搅拌至少50min使之充分溶解;①Measure 90%-95% of the total volume of water for injection, and when the temperature drops to 35-40°C, weigh an equivalent of 50L dry powder medium, that is, 0.925kg dry powder (does not contain glutamine, PluronicF-68 and serum) dissolved in Wherein, stirring for at least 50 minutes to fully dissolve it;
②在上述步骤①得到的溶液中加入谷氨酰胺36.5g,搅拌15min;② Add 36.5 g of glutamine to the solution obtained in the above step ①, and stir for 15 minutes;
③在上述步骤②得到的溶液中加入抗剪切保护剂PluronicF-6850.0g,搅拌15min;③ Add 50.0 g of anti-shear protection agent PluronicF-6850.0 g to the solution obtained in the above step ②, and stir for 15 minutes;
④在上述步骤③得到的溶液中加入1%(v/v)血清,充分混匀;④ Add 1% (v/v) serum to the solution obtained in the above step ③, and mix well;
⑤在上述步骤④得到的溶液中加入一定量4.0mol/L氢氧化钠或1.0mol/L盐酸溶液,调pH值为7.0~7.2;⑤ Add a certain amount of 4.0mol/L sodium hydroxide or 1.0mol/L hydrochloric acid solution to the solution obtained in the above step ④, and adjust the pH value to 7.0-7.2;
⑥在上述步骤⑤得到的溶液中加入冷却的注射用水,定容至终体积50L;⑥ Add cooled water for injection to the solution obtained in the above step ⑤, and set the volume to a final volume of 50L;
⑦在上述步骤⑥得到的溶液用孔径0.22μm的滤芯除菌过滤,置4℃保存。⑦ The solution obtained in the above step ⑥ is sterilized and filtered with a filter element with a pore size of 0.22 μm, and stored at 4°C.
1.4试剂与设备1.4 Reagents and equipment
主要试剂:美国Waters氨基酸分析色谱柱(5μm,150×4.6mmol);20种氨基酸标样;乙腈(色谱纯);醋酸钠(分析纯);醋酸(分析纯);三乙胺(TEA);苯异硫氰酸酯(PITC);Main reagents: American Waters amino acid analysis column (5μm, 150×4.6mmol); 20 amino acid standard samples; acetonitrile (chromatographically pure); sodium acetate (analytical pure); acetic acid (analytical pure); triethylamine (TEA); Phenylisothiocyanate (PITC);
主要仪器:细胞分析仪(德国INNOVATIS公司);显微镜(日本Olympus);美国Waters高效液相色谱仪;NOVAPLUS100生化分析仪、5L生物反应器(美国NBS),500L生物反应器(自主设计委托生物反应器厂家生产)。Main instruments: cell analyzer (Innovatis, Germany); microscope (Olympus, Japan); American Waters high-performance liquid chromatography; NOVAPLUS100 biochemical analyzer, 5L bioreactor (US NBS), 500L bioreactor (independently designed and commissioned bioreactor device manufacturers).
2方法2 methods
2.1细胞计数与分析2.1 Cell count and analysis
2.1.1取样:用无菌的吸管吸取细胞;2.1.1 Sampling: absorb the cells with a sterile pipette;
2.1.2加样:用吸管轻轻吹打细胞悬液,用移液器将细胞样品20ul与CASYTON细胞分析缓冲液10ml反复混匀,用细胞分析仪进行分析。2.1.2 Adding samples: pipette the cell suspension gently, use a pipette to mix 20ul of cell samples and 10ml of CASYTON cell analysis buffer repeatedly, and analyze with a cell analyzer.
2.1.3检测:根据细胞分析仪测定的结果,计算细胞活率、密度及细胞生长比率,确定细胞的增殖能力。2.1.3 Detection: Calculate the cell viability, density and cell growth ratio according to the results measured by the cell analyzer to determine the proliferation ability of the cells.
2.2细胞复苏与培养2.2 Cell Recovery and Culture
①从悬浮BHK-21细胞工作库取细胞一支,迅速置于40℃水浴中解冻;①Take one cell from the suspended BHK-21 cell working bank, and quickly place it in a 40°C water bath to thaw;
②将①所得到的细胞在1000rpm转速下,离心4min,弃上清,加入适量含有5%血清的培养液重悬,复苏后静置培养于T100细胞方瓶内,传2~3代,细胞长满单层后用胰蛋白酶消化;②Centrifuge the cells obtained in ① at 1000rpm for 4min, discard the supernatant, add an appropriate amount of culture medium containing 5% serum to resuspend, and culture it in a T100 cell square bottle after recovery, pass 2 to 3 generations, and the cells Digest with trypsin after overgrown monolayer;
③将②所得到的细胞转移至250ml三角瓶中,37℃振荡悬浮培养,摇床转速为90r/min,pH值为7.0~7.2,每日用8%NaHCO3调pH值,待细胞培养体积达到规定数量后,收集细胞,以备后续作细胞种子。③Transfer the cells obtained in ② into a 250ml Erlenmeyer flask, culture in suspension at 37°C with shaking, the speed of the shaker is 90r/min, the pH value is 7.0-7.2, adjust the pH value with 8% NaHCO 3 every day, until the cell culture volume After the specified number is reached, the cells are collected for subsequent cell seeding.
2.3BHK-21细胞在5L生物反应器传代培养2.3 Subculture of BHK-21 cells in 5L bioreactor
将上述2.2收集的细胞转入5L生物反应器中培养,接种密度为0.50×106cells/ml,培养体积4000ml,培养设定参数:温度37℃、DO值为68%、pH值为7.0、转速120r/min,均自动控制。培养48h,传代培养40日(20代)。Transfer the cells collected in the above 2.2 into a 5L bioreactor for culture, the inoculation density is 0.50×10 6 cells/ml, the culture volume is 4000ml, and the culture setting parameters are: temperature 37°C, DO value 68%, pH value 7.0, The speed is 120r/min, all controlled automatically. Cultured for 48 hours, subcultured for 40 days (20 generations).
2.4BHK-21细胞在500L生物反应器传代培养2.4 Subculture of BHK-21 cells in a 500L bioreactor
将上述收集的细胞种子在500L生物反应器上扩大培养,接种密度0.55×106个/ml,反应器控制参数:温度为37.0℃、DO值为70.0%、pH值为7.1、转速100r/min,均自动控制。培养48h,传代培养40日(20代)。The cell seeds collected above were expanded and cultured on a 500L bioreactor, the inoculation density was 0.55×10 6 cells/ml, and the reactor control parameters were: temperature 37.0°C, DO value 70.0%, pH value 7.1, speed 100r/min , are automatically controlled. Cultured for 48 hours, subcultured for 40 days (20 generations).
3、结果3. Results
结合细胞代谢流监测结果,确定主要影响细胞生长代谢的各个营养物质的含量及细胞代谢过程中对副产物的耐受浓度,对此培养基进行5L和500L不同规模细胞悬浮培养的应用验证,不同规模下培养细胞稳定性传代情况如图5所示,表明应用本发明确定的培养基连续培养BHK-21细胞40日(20代),密度均在3.5×106个/ml以上,且其活率均高于94%,因此,此培养基ZN-MEM可应用于BHK-21细胞大规模培养。Combined with the monitoring results of cell metabolic flow, the content of various nutrients that mainly affect cell growth and metabolism and the tolerance concentration of by-products in the process of cell metabolism are determined. The medium is used to verify the application of 5L and 500L cell suspension culture in different scales. The stability and passage of cells cultured on a large scale is shown in Figure 5, which shows that BHK-21 cells were continuously cultured for 40 days (20 generations) using the medium determined by the present invention, and the density was all above 3.5×10 6 cells/ml, and their viability The rates are all higher than 94%. Therefore, this medium ZN-MEM can be applied to large-scale cultivation of BHK-21 cells.
实施例三不同培养基培养的BHK21细胞对病毒增殖的影响Effect of BHK21 cells cultured in different mediums on virus proliferation in embodiment three
1材料和方法1 Materials and methods
1.1材料1.1 Materials
1.1.1细胞1.1.1 Cells
BHK-21-P细胞购自ATCC,来源:HamsterSyrianKidney,中农威特生物科技股份有限公司保存,试验细胞已传F18代。BHK-21-P cells were purchased from ATCC, source: HamsterSyrianKidney, preserved by Zhongnong Weite Biotechnology Co., Ltd., and the test cells have been passed to F18 generation.
1.1.2培养基1.1.2 Medium
BHK-21细胞商业化的低血清培养基,即:BHK-21MEM、BHK-21GMEM、SLMBHK-21,分别命名为A、B和C培养基;本发明培养基ZN-MEM,命名为D培养基,配方与实施例二中的培养基相同。The commercialized low-serum medium of BHK-21 cells, namely: BHK-21MEM, BHK-21GMEM, SLMBHK-21, are named as A, B and C medium respectively; the medium ZN-MEM of the present invention is named as D medium , the formulation is identical to the medium in Example two.
1.1.3培养基添加物1.1.3 Medium supplements
谷氨酰胺、PluronicF-68、柠檬酸铁、转铁蛋白、腐胺、激素、脂类物质购于SIGMA公司,大豆蛋白水解物、超滤植物蛋白胨、酵母提取物等购于北京试剂公司。Glutamine, Pluronic F-68, ferric citrate, transferrin, putrescine, hormones, and lipids were purchased from SIGMA Company, and soybean protein hydrolyzate, ultrafiltration plant peptone, yeast extract, etc. were purchased from Beijing Reagent Company.
1.1.4其它试剂与设备1.1.4 Other reagents and equipment
碳酸氢钠、氢氧化钠、盐酸等常用试剂为国产分析纯,Commonly used reagents such as sodium bicarbonate, sodium hydroxide, and hydrochloric acid are domestic analytically pure,
主要仪器:细胞计数仪(德国INNOVATIS公司),NOVAPLUS100生化分析仪(美国NovaBiomedical公司),倒置显微镜(日本Olympus)等。Main instruments: cell counter (Innovatis, Germany), NOVAPLUS100 biochemical analyzer (NovaBiomedical, USA), inverted microscope (Olympus, Japan), etc.
1.2方法1.2 Method
1.2.1BHK-21细胞复苏与悬浮培养1.2.1 Recovery and suspension culture of BHK-21 cells
①从悬浮BHK-21细胞工作库取细胞一支,迅速置于40℃水浴中解冻;①Take one cell from the suspended BHK-21 cell working bank, and quickly place it in a 40°C water bath to thaw;
②将①所得到的细胞在1000rpm转速下,离心4min,弃上清,加入适量含有5%血清的培养液重悬,复苏后静置培养于T100细胞方瓶内,传2~3代,细胞长满单层后用胰蛋白酶消化;②Centrifuge the cells obtained in ① at 1000rpm for 4min, discard the supernatant, add an appropriate amount of culture medium containing 5% serum to resuspend, and culture it in a T100 cell square bottle after recovery, pass 2 to 3 generations, and the cells Digest with trypsin after overgrown monolayer;
③将②所得到的细胞转移至250ml三角瓶中,37℃振荡悬浮培养,摇床转速为90r/min,pH值7.0~7.2,每日用8%NaHCO3调两次pH值,待细胞培养体积达到100ml,取上述处于对数生长期的细胞,按1:6~1:10转入1000ml三角瓶中扩大培养。③Transfer the cells obtained in ② into a 250ml Erlenmeyer flask, culture in suspension at 37°C with shaking, the shaker speed is 90r/min, the pH value is 7.0-7.2, adjust the pH value twice a day with 8% NaHCO 3 , and wait for the cell culture When the volume reaches 100ml, take the above-mentioned cells in the logarithmic growth phase and transfer them to a 1000ml Erlenmeyer flask at a ratio of 1:6 to 1:10 for expansion.
1.2.2BHK-21细胞在不同培养基中的批式培养1.2.2 Batch culture of BHK-21 cells in different media
取生长良好的无血清BHK-21悬浮细胞,以同一初始密度0.60×106cells/ml分别接种于A、B、C和D四种培养基中,在37℃、100r/min、PH值为7.0培养条件下进行批式培养。在培养至0h、24h、48h、72h、96h和120h取细胞样品,倒置显微镜下进行形态学观察,以细胞密度和细胞活率为评价指标,分析细胞生长情况。Take well-grown serum-free BHK-21 suspension cells and inoculate them in four mediums A, B, C and D at the same initial density of 0.60×10 6 cells/ml, and inoculate them at 37°C, 100r/min, and pH Batch culture was carried out under 7.0 culture conditions. Cell samples were taken after 0h, 24h, 48h, 72h, 96h and 120h of culture, observed under an inverted microscope, and cell growth was analyzed using cell density and cell viability as evaluation indicators.
1.2.3主要营养物质和代谢副产物等细胞代谢参数的测定1.2.3 Determination of cell metabolism parameters such as main nutrients and metabolic by-products
取上述批式培养过程中0h、24h、48h和96h细胞样品,800r/min进行离心,留上清液,采用NOVAPLUS100生化分析仪分析,检测BHK-21细胞在不同无血清培养基条件下,细胞培养液中的谷氨酰胺、葡萄糖、氨、乳酸浓度。Take the cell samples of 0h, 24h, 48h and 96h in the above batch culture process, centrifuge at 800r/min, keep the supernatant, and use NOVAPLUS100 biochemical analyzer to analyze the BHK-21 cells under different serum-free medium conditions. Glutamine, glucose, ammonia, and lactic acid concentrations in the culture medium.
1.2.4不同培养基培养的BHK21细胞对口蹄疫病毒增殖的影响1.2.4 Effects of BHK21 cells cultured in different media on the proliferation of foot-and-mouth disease virus
取A、B、C和D培养基培养的细胞,分别接种口蹄疫病毒Re-AWH/09型、O/MYA98/BY/2010和FMD/Asia1JSL/06毒株,设定控制参数:温度为36.5~37.0℃,pH值为7.4~7.6,DO值为60.0%~70.0%,搅拌转速为40~60r/min。当细胞病变率在90%以上,收获病毒,记录收获病毒的时间,按常规法测定收获病毒液的TCID50、LD50和有效抗原146S含量。Take the cells cultured in medium A, B, C and D, and inoculate the Re-AWH/09 type, O/MYA98/BY/2010 and FMD/Asia1JSL/06 strains of foot-and-mouth disease virus respectively, and set the control parameters: the temperature is 36.5~ 37.0°C, pH value 7.4-7.6, DO value 60.0%-70.0%, stirring speed 40-60r/min. When the cytopathic rate was above 90%, the virus was harvested, the time of harvesting the virus was recorded, and the TCID 50 , LD 50 and effective antigen 146S content of the harvested virus liquid were measured by conventional methods.
2结果2 results
2.1BHK-21细胞在不同无血清培养基中细胞培养形态的比较2.1 Comparison of cell culture morphology of BHK-21 cells in different serum-free media
BHK-21细胞在四种培养基中细胞形态如图6所示,可见BHK-21细胞在上述四种养基中培养,细胞形态差异较大,其中D图中优化的培养基培养的细胞形态优于其它A、B和C培养基,细胞透亮、饱满、圆润,边界清晰,细胞大小正常(一般在10.0~11.0μm)。The cell morphology of BHK-21 cells in the four culture media is shown in Figure 6. It can be seen that BHK-21 cells are cultured in the above four culture media, and the cell morphology is quite different. Among them, the cell morphology of the optimized culture medium in Figure D Better than other mediums A, B and C, the cells are bright, plump, round, with clear borders, and the cell size is normal (generally 10.0-11.0 μm).
2.2BHK-21细胞在不同培养基中批式培养细胞生长曲线比较2.2 Comparison of growth curves of BHK-21 cells in batch culture in different media
BHK-21细胞在四种培养基中批式培养的生长曲线如图7所示。从图7可知,在批式培养的整个过程中,优化的D培养基细胞生长最快,细胞活率高,在培养至72h,最大活细胞密度达8.42×106cells/ml,细胞活率96.88%。可见,优化的D培养基更适合于BHK-21细胞培养。The growth curves of BHK-21 cells cultured in batch in four media are shown in Fig. 7 . It can be seen from Figure 7 that during the whole process of batch culture, the optimized D medium had the fastest cell growth and high cell viability. After culturing for 72 hours, the maximum viable cell density reached 8.42×10 6 cells/ml, and the cell viability 96.88%. It can be seen that the optimized D medium is more suitable for BHK-21 cell culture.
2.3主要营养物质和代谢副产物等细胞代谢参数的测定2.3 Determination of cell metabolism parameters such as main nutrients and metabolic by-products
应用NOVAPLUS100生化分析仪,对培养0h、24h、48h和96h细胞上清液进行谷氨酰胺、葡萄糖、氨及乳酸浓度的测定。NOVAPLUS100 biochemical analyzer was used to measure the concentration of glutamine, glucose, ammonia and lactic acid in the supernatant of cells cultured for 0h, 24h, 48h and 96h.
BHK-21批式培养过程中葡萄糖和乳酸浓度的变化如图8所示,BHK-21批式培养过程中谷氨酰胺和氨浓度的变化如图9所示。Figure 8 shows the changes of glucose and lactic acid concentrations during BHK-21 batch culture, and Figure 9 shows the changes of glutamine and ammonia concentrations during BHK-21 batch culture.
从图8、9可见,BHK-21细胞在四种培养基培养条件下,细胞培养液中的主要营养物质葡萄糖和谷氨酰胺浓度均随着培养时间的延长而逐渐降低,呈培养前期下降较快、中后期下降减缓的趋势,细胞培养上清液中的乳酸和氨浓度均随着培养时间的延长而不断累积。It can be seen from Figures 8 and 9 that under the culture conditions of four mediums for BHK-21 cells, the concentration of the main nutrients glucose and glutamine in the cell culture medium gradually decreased with the prolongation of the culture time, showing a decrease in the early stage of culture compared with that in the culture period. The trend of slowing down in the fast, middle and late stages, the concentration of lactic acid and ammonia in the cell culture supernatant both accumulated continuously with the prolongation of the culture time.
通过比较发现,D培养基中葡萄糖和谷氨酰胺浓度较低,其代谢副产物氨和乳酸浓度也较低(乳酸和氨浓度达到19mM、8mM时,对BHK-21细胞的生长产生严重的抑制作用),说明D培养基中葡萄糖和谷氨酰胺浓度比例达到最优化,从而优化了细胞代谢途径,可促进细胞的增殖。By comparison, it was found that the concentration of glucose and glutamine in D medium was low, and the concentration of its metabolic by-products ammonia and lactic acid was also low (when the concentration of lactic acid and ammonia reached 19mM and 8mM, the growth of BHK-21 cells was severely inhibited effect), indicating that the concentration ratio of glucose and glutamine in D medium is optimized, thereby optimizing the cell metabolic pathway and promoting cell proliferation.
2.4不同培养基培养的BHK-21细胞对口蹄疫病毒增殖的影响2.4 Effects of BHK-21 cells cultured in different media on the proliferation of foot-and-mouth disease virus
表3不同培养基培养的BHK-21细胞对口蹄疫病毒增殖的影响The BHK-21 cell that table 3 different culture medium is cultured is to the impact of foot-and-mouth disease virus proliferation
表3结果表明:用上述四种培养基培养的BHK-21悬浮细胞生产口蹄疫病毒液TCID50、LD50均达到工业化生产的要求,而自制的低血清培养基D生产的不同型口蹄疫病毒的细胞病变时间缩短,有效抗原146S含量提高43%,优于A、B、C商业化培养基,这为FMD高品质疫苗生产奠定了基础。The results in Table 3 show that: the TCID 50 and LD 50 of the BHK-21 suspension cells cultured with the above four mediums to produce the FMD virus solution all meet the requirements of industrial production, while the cells of different types of FMD virus produced by the self-made low serum medium D The lesion time is shortened, and the effective antigen 146S content is increased by 43%, which is better than A, B, and C commercial media, which lays the foundation for the production of high-quality FMD vaccines.
3结论3 Conclusion
用自行研制的个性化培养基与三种商业化的低血清培养基分别培养BHK-21细胞,研究BHK-21细胞在不同培养基中的生长与病毒增殖状况,结果表明,BHK-21细胞在优化的D培养基中培养,优于A、B、C商业化培养基,培养的细胞饱满、透亮,细胞生长速度较快,细胞代谢副产物氨和乳酸浓度低,能连续稳定传代培养,细胞密度提高28%左右,生产的口蹄疫病毒液有效抗原含量提高43%,能保证高品质疫苗的生产。BHK-21 cells were cultured with self-developed personalized medium and three commercial low-serum mediums, and the growth and virus proliferation of BHK-21 cells in different mediums were studied. The results showed that BHK-21 cells were in Cultured in the optimized D medium, which is better than A, B, and C commercial medium, the cultured cells are plump and bright, the cell growth rate is fast, the concentration of ammonia and lactic acid by-products of cell metabolism is low, and it can be continuously and stably subcultured. The density is increased by about 28%, and the effective antigen content of the produced foot-and-mouth disease virus liquid is increased by 43%, which can ensure the production of high-quality vaccines.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510980603.7A CN105505853B (en) | 2015-12-23 | 2015-12-23 | A low-serum medium for high-density suspension culture of BHK-21 cells and its application in the proliferation of foot-and-mouth disease virus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510980603.7A CN105505853B (en) | 2015-12-23 | 2015-12-23 | A low-serum medium for high-density suspension culture of BHK-21 cells and its application in the proliferation of foot-and-mouth disease virus |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105505853A true CN105505853A (en) | 2016-04-20 |
CN105505853B CN105505853B (en) | 2019-03-15 |
Family
ID=55714151
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510980603.7A Active CN105505853B (en) | 2015-12-23 | 2015-12-23 | A low-serum medium for high-density suspension culture of BHK-21 cells and its application in the proliferation of foot-and-mouth disease virus |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105505853B (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106676058A (en) * | 2016-12-09 | 2017-05-17 | 中农威特生物科技股份有限公司 | High-density fed-batch culture method of BHK21 suspended cells and application of high-density fed-batch culture method to foot-and-mouth disease viral multiplication |
CN107435037A (en) * | 2016-05-27 | 2017-12-05 | 上海倍谙基生物科技有限公司 | A kind of serum free medium for bhk cell |
CN109628411A (en) * | 2018-12-26 | 2019-04-16 | 内蒙古金源康生物工程有限公司 | FMD antigen enhanced culture medium and preparation method and application thereof |
CN110643568A (en) * | 2019-09-23 | 2020-01-03 | 山东甲骨文生物科技有限公司 | Low-serum culture medium for BHK-21 cell culture and corresponding virus production |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114181890B (en) * | 2021-11-30 | 2023-07-25 | 中农威特生物科技股份有限公司 | Milk hamster kidney cell BHK-21-E-200 and application thereof as virus vaccine production cell strain |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040001864A1 (en) * | 2000-06-29 | 2004-01-01 | King Andrew Maurice Quatermain | Vaccine against foot-and-mouth disease |
CN102268403A (en) * | 2011-08-01 | 2011-12-07 | 上海米迪生物技术有限公司 | Serum-free culture medium applicable to large-scale single-cell suspension culture of baby hamster kidney cell |
CN103555658A (en) * | 2013-11-07 | 2014-02-05 | 令世鑫 | Serum-free medium for full suspension cultivation of BHK (Baby Hamster Kidney)-21 cell |
CN105018416A (en) * | 2014-07-15 | 2015-11-04 | 内蒙古金源康生物工程有限公司 | Serum-free animal origin-free culture medium for suspension culture of BHK-21 cells and preparation method of serum-free animal origin-free culture medium |
-
2015
- 2015-12-23 CN CN201510980603.7A patent/CN105505853B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040001864A1 (en) * | 2000-06-29 | 2004-01-01 | King Andrew Maurice Quatermain | Vaccine against foot-and-mouth disease |
CN102268403A (en) * | 2011-08-01 | 2011-12-07 | 上海米迪生物技术有限公司 | Serum-free culture medium applicable to large-scale single-cell suspension culture of baby hamster kidney cell |
CN103555658A (en) * | 2013-11-07 | 2014-02-05 | 令世鑫 | Serum-free medium for full suspension cultivation of BHK (Baby Hamster Kidney)-21 cell |
CN105018416A (en) * | 2014-07-15 | 2015-11-04 | 内蒙古金源康生物工程有限公司 | Serum-free animal origin-free culture medium for suspension culture of BHK-21 cells and preparation method of serum-free animal origin-free culture medium |
Non-Patent Citations (2)
Title |
---|
MIGUEL A. MARTIN-ACEBES等: "Cell density-dependent expression of viral antigens during persistence of foot-and-mouth disease virus in cell culture", 《VIROLOGY》 * |
汪梁,等: "Mixture与响应面法结合开发BHK-21细胞无血清悬浮培养基", 《生物技术通报》 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107435037A (en) * | 2016-05-27 | 2017-12-05 | 上海倍谙基生物科技有限公司 | A kind of serum free medium for bhk cell |
CN107435037B (en) * | 2016-05-27 | 2021-12-21 | 上海倍谙基生物科技有限公司 | Serum-free medium for BHK (baby hamster kidney) cells |
CN106676058A (en) * | 2016-12-09 | 2017-05-17 | 中农威特生物科技股份有限公司 | High-density fed-batch culture method of BHK21 suspended cells and application of high-density fed-batch culture method to foot-and-mouth disease viral multiplication |
CN109628411A (en) * | 2018-12-26 | 2019-04-16 | 内蒙古金源康生物工程有限公司 | FMD antigen enhanced culture medium and preparation method and application thereof |
CN110643568A (en) * | 2019-09-23 | 2020-01-03 | 山东甲骨文生物科技有限公司 | Low-serum culture medium for BHK-21 cell culture and corresponding virus production |
Also Published As
Publication number | Publication date |
---|---|
CN105505853B (en) | 2019-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105505853A (en) | Low-serum culture medium for high-density suspension culture of BHK-21 cells and application of low-serum culture medium in proliferation of FMDVs (foot and mouth disease viruses) | |
CN105861422B (en) | It is a kind of adapt to serum-free suspend full culture mdck cell system preparation method and the mdck cell system that is obtained by the preparation method | |
CN106011083A (en) | Preparation method of avian influenza virus growing in serum-free full-suspended cultured MDCK cells and obtained avian influenza virus | |
US11629338B2 (en) | Method for acclimating and suspending Vero and second order production process for virus | |
CN108300704B (en) | Method for suspension culture of infectious bronchitis virus by using continuous cell line | |
CN1807599A (en) | Method for safe continuous enclosed cell culture, virus production/ inactivation | |
CN105112363A (en) | Serum-free medium for human adipose-derived stem cells and preparation method thereof | |
CN102178946B (en) | Application of baby hamster kidney(BHK)-21 cell serum-free suspension culture technology in foot-and-mouth disease vaccine production | |
CN103898041A (en) | Culture method of hybridomas | |
CN102807964B (en) | Method for scale-up culture of animal cells | |
CN113564127A (en) | Method for large-scale suspension culture of avian adenovirus | |
CN103160478B (en) | Optimized technological method for amplifying recombinant adenovirus by using bioreactor | |
CN102861329A (en) | Production method of canine parvovirus inactivated vaccine by utilizing bioreactor | |
CN107988143A (en) | One plant of BHK-21 cells Gs cell line | |
CN112342158B (en) | Mycoplasma gallisepticum culture medium and preparation method thereof | |
CN103555674A (en) | Multiple-virus-obtaining process for proliferating porcine reproductive and respiratory syndrome virus by Marc (rhesus monkey kidney cell)-145 cell cultured by microcarriers | |
CN102743749B (en) | Method for preparing live attenuated rubella vaccine in human diploid cells by using basket-type bioreactor | |
CN108866128A (en) | A kind of raising kasugarnycin biological value method | |
CN105861416B (en) | It is a kind of for the serum free medium and its preparation method and application for cultivating insect cell that suspends entirely | |
CN202124632U (en) | Stem cell culture perfusing device | |
CN106676058B (en) | BHK21 suspension cell high-density fed-batch culture method and application thereof in foot-and-mouth disease virus proliferation | |
CN102657859A (en) | Method for producing avian influenza vaccine by using cells cultured by spherical microcarrier bioreactor | |
CN111662882A (en) | Method for proliferating avian influenza virus by MDCK cell line | |
CN114409745B (en) | Production method for efficiently secreting and expressing porcine epidemic diarrhea virus S1 protein | |
CN112680422A (en) | Method for proliferating H9N2 subtype avian influenza virus by full-suspension serum-free MDCK cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |